Login / Signup

Iopofosine I-131 treatment in late-line patients with relapsed/refractory multiple myeloma post anti-BCMA immunotherapy.

Jarrod LongcorNatalie S CallanderKate OliverAsher Chanan-KhanSikandar Ailawadhi
Published in: Blood cancer journal (2022)
Keyphrases
  • multiple myeloma
  • acute lymphoblastic leukemia
  • acute myeloid leukemia
  • diffuse large b cell lymphoma